Stockscreener 앱 받기
2.38
2.15%
0.05
시간 외 거래:
2.35
-0.03
-1.26%
전일 마감가:
$2.33
열려 있는:
$2.35
하루 거래량:
58,987
Relative Volume:
1.79
시가총액:
$160.83M
수익:
-
순이익/손실:
$-28.95M
주가수익비율:
-7.4375
EPS:
-0.32
순현금흐름:
$-29.35M
1주 성능:
+3.93%
1개월 성능:
-2.86%
6개월 성능:
-19.32%
1년 성능:
-37.20%
1일 변동 폭
$2.26
$2.38
1주일 범위
$2.26
$2.38
52주 변동 폭
$1.75
$3.90
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 개시 | Piper Sandler | Overweight |
| 2022-04-04 | 개시 | Citigroup | Buy |
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
Radiopharmaceutical Market 2024 – Industry Opportunities, Challenges, Value Chain and Sales Channels Analysis 2032 | Clarity Pharmaceuticals - 대구포스트
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Update - MarketBeat
Alpha Emitter Market Outlook, Key Trends and Growth Projections from 2024 to 2032 - 대구포스트
Alpha Emitter Market on the Rise: A Study on its Growth Prospects - openPR
Alpha Tau Medical Ltd.FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC - Marketscreener.com
FDA approves study of Alpha Tau’s Alpha DaRT for recurrent cSCC treatment - Yahoo Finance
Global Alpha Emitter Market Set to Reach $ 1751.5 Million by 2032, Expanding at 11.25% CAGR - 대구포스트
Alpha Tau’s Alpha DaRT Gains FDA Study Approval - TipRanks
Alpha Tau Medical Ltd. Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC - Marketscreener.com
Alpha Tau Announces FDA Approval of IDE to Initiate - GlobeNewswire
Sidoti Events, LLC's Virtual September Small-Cap Conference - Yahoo Finance
Alpha Tau Medical’s Alpha DaRT Technology Shows Breakthrough Results in Cancer Trials - Proactive Investors Australia
Alpha Tau Medical Share PriceDRTS, RNS News, Articles, Quotes, & Charts (NASDAQ:DRTS) - Proactive Investors Australia
23,323 Shares in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Purchased by Caprock Group LLC - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 5.3% - Defense World
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 63.4% in August - MarketBeat
Top 230+ startups in Radiation Therapy Devices in Sep, 2024 - Tracxn
Radiotherapy Devices Market Scope In The New Analysis By Leading Research Firm - WhaTech
Kromek Group (LON:KMK) Share Price Passes Below 200-Day Moving Average of $6.56 - Defense World
Aptus Capital Advisors LLC Raises Holdings in Alpha Tau Medical Ltd. (NASDAQ:DRTS) - Defense World
Aptus Capital Advisors LLC Sells 1,326 Shares of JPMorgan Municipal ETF (BATS:JMUB) - Defense World
Medical Lasers Market 2024: Exploring Industry Demand, Technological Advancements, And Future Prospects - WhaTech
Oncology Devices Market Key Trends, Latest Insights, Future Trends And Forecast To 2033 - WhaTech
DRTS: Company Seeks to Develop Significant Advance in Cancer Therapy with Alpha DaRT - Yahoo Finance
Financial Comparison: Assure (NASDAQ:IONM) versus Alpha Tau Medical (NASDAQ:DRTS) - Defense World
HP Inc. (NYSE:HPQ) Shares Sold by Cambridge Investment Research Advisors Inc. - Defense World
Capital Group Dividend Growers ETF (NYSEARCA:CGDG) Stock Position Lifted by Cambridge Investment Research Advisors Inc. - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 10.3% - Defense World
Alpha Tau Medical Ltd. Forecasted to Post FY2024 Earnings of ($0.47) Per Share (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical to Showcase Cancer Therapy at Global Conferences - TipRanks
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Invest - Marketscreener.com
Alpha Tau to Participate in the H.C. Wainwright 26th Annual - GlobeNewswire
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Invest - StockTitan
Alpha Tau Medical Ltd. to Post FY2024 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:DRTS) - Defense World
SIR Royalty Income Fund (TSE:SRV.UN) Shares Cross Below Two Hundred Day Moving Average of $13.70 - Defense World
PositiveID (OTCMKTS:PSID) Shares Cross Above 200-Day Moving Average of $0.00 - Defense World
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Invest - Yahoo Finance
Burlington Stores (BURL) to Release Quarterly Earnings on Thursday - Defense World
Alpha Tau Medical stock holds Buy rating on clinical trial updates - Investing.com India
Alpha Tau Medical stock holds Buy rating on clinical trial updates - Investing.com
Alpha Tau Medical’s (DRTS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
SelectQuote, Inc. (NYSE:SLQT) Stock Position Decreased by California State Teachers Retirement System - Defense World
Alpha Tau Medical's (DRTS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Bank of America Increases Lumentum (NASDAQ:LITE) Price Target to $50.00 - Defense World
8X8 (NASDAQ:EGHT) Downgraded by StockNews.com - Defense World
Alpha Tau Medical (NASDAQ:DRTS) Rating Reiterated by Piper Sandler - Defense World
StockNews.com Initiates Coverage on CVD Equipment (NASDAQ:CVV) - Defense World
Alpha Tau Medical maintains stock target with Overweight rating on operating loss - Investing.com Australia
Piper Sandler Reaffirms "Overweight" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical maintains stock target with Overweight rating on operating loss - Investing.com Canada
Alpha Tau Medical maintains stock target with Overweight rating on operating loss - Investing.com
Alpha Tau Medical Ltd (DRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
4.86%
자본화:
|
볼륨(24시간):